Both CCNE1 and CCNE2 are expressed at higher levels in breast cancer, with an association of both genes to increased tumour grade [105,106], estrogen receptor (ER) negative status [105,106], progesterone receptor negative status [106], and proliferative index by Ki67 staining [83,105]. Here, ESR1 is linked to breast carcinoma.